Novartis to acquire biotech company CoStim Pharmaceuticals

09:33 AM | February 17, 2014 | Natasha Alperowicz

Novartis announced today that it is buying CoStim Pharmaceuticals (Cambridge, MA), a privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals...